<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1">
<!-- Latest compiled and minified CSS -->
<link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.4/css/bootstrap.min.css">
<!-- Optional theme -->
<link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.4/css/bootstrap-theme.min.css">
<!-- Latest compiled and minified JavaScript -->
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.4/js/bootstrap.min.js"></script>
<style>img { width: 150px; height: auto; }</style>
</head>
<body role="document">
<div class="container theme-showcase" role="main">
<h3>FDA panel to discuss Ebola vaccine development in May</h3>
<table class="table table-striped"><tr><td>1</td><td>The federal health regulator would discuss the development of vaccines on May 12, it announced on its website on Wednesday.</td></tr>
<tr><td>2</td><td>Ebola has so far claimed about 10,000 lives in Sierra Leone, Liberia and Guinea.</td></tr>
<tr><td>3</td><td>Only a handful of cases have been reported in the United States, Spain and Britain.</td></tr>
<tr><td>4</td><td>The resurgence of the virus last year prompted drugmakers from across the world to develop new treatments that are in different stages of studies.</td></tr>
<tr><td>5</td><td>Mapp Biopharmaceutical's ZMapp and a compound from Tekmira Pharmaceuticals Corp have so far shown they could cure non-human primates given injections of Ebola virus.</td></tr>
<tr><td>6</td><td>Other companies that are testing potential treatments for the deadly infection are GlaxoSmithKline, Sarepta Pharmaceuticals Inc, Novavax Inc, Merck & Co and Johnson & Johnson.</td></tr>
<tr><td>7</td><td>The World Health Organization said it will decide on mass vaccination against the virus in August.</td></tr>
</table></body></div></html>